ArticleMayo Clinic proceedings2021

Effects of Empagliflozin Treatment on Cardiac Biomarkers in Adults With Metabolically Healthy Obesity: Results From a Randomized, Placebo-Controlled Clinical Trial.

Sadiya S Khan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.